RESEARCHER PROFILE

Beth Y. Karlan

← Back to University of California, Los Angeles

B

University of California, Los Angeles

Ovarian cancer diagnosis and treatmentBRCA gene mutations in cancerPARP inhibition in cancer therapyGenetic Associations and EpidemiologyEndometrial and Cervical Cancer Treatments

Beth Y. Karlan works in Ovarian cancer diagnosis and treatment, BRCA gene mutations in cancer, PARP inhibition in cancer therapy, Genetic Associations and Epidemiology, Endometrial and Cervical Cancer Treatments. Recorded institutional associations include University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center.

1,115Publications
83,649Citations
128H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. The Immune Landscape of Cancer

    2018 · 5,739 citations
  2. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

    2018 · 3,681 citations
  3. The repertoire of mutational signatures in human cancer

    2020 · 3,468 citations
  4. Oncogenic Signaling Pathways in The Cancer Genome Atlas

    2018 · 3,175 citations
  5. Pan-cancer analysis of whole genomes

    2020 · 3,054 citations
  6. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer

    2018 · 2,521 citations
  7. Comprehensive Characterization of Cancer Driver Genes and Mutations

    2018 · 2,298 citations
  8. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

    2018 · 2,172 citations
  9. Integrated genomic and molecular characterization of cervical cancer

    2017 · 1,564 citations
  10. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

    2015 · 1,367 citations
  11. Ovarian cancer

    2016 · 1,264 citations
  12. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

    2018 · 1,136 citations
  13. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    2021 · 1,112 citations
  14. Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers

    2008 · 1,083 citations
  15. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

    2017 · 1,063 citations
  16. Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    2018 · 1,062 citations
  17. The evolutionary history of 2,658 cancers

    2020 · 1,046 citations
  18. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

    2018 · 1,022 citations
  19. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

    2015 · 902 citations
  20. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

    2018 · 897 citations
  21. Patterns of somatic structural variation in human cancer genomes

    2020 · 866 citations
  22. Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines

    2018 · 852 citations
  23. Pathogenic Germline Variants in 10,389 Adult Cancers

    2018 · 833 citations
  24. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

    2018 · 770 citations
  25. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

    2018 · 734 citations

← Return to the university profile